share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

Moderna | 4：持股变动声明-高管 Klinger Shannon Thyme

SEC announcement ·  03/01 17:30
Moomoo AI 已提取核心信息
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of 670 shares of common stock on 02/29/2024, as per the latest SEC filings. The transaction was executed at a price of $94.572 per share, resulting in a total sale value of $63,363.24. Prior to this sale, Klinger acquired 1,315 shares through the exercise of derivative securities on 02/28/2024. Following these transactions, Klinger's direct holdings in Moderna amount to 8,557 shares of common stock.
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a sale of 670 shares of common stock on 02/29/2024, as per the latest SEC filings. The transaction was executed at a price of $94.572 per share, resulting in a total sale value of $63,363.24. Prior to this sale, Klinger acquired 1,315 shares through the exercise of derivative securities on 02/28/2024. Following these transactions, Klinger's direct holdings in Moderna amount to 8,557 shares of common stock.
Moderna, Inc. '根据美国证券交易委员会的最新文件，首席法务官香农·泰里姆·克林格于2024年2月29日完成了670股普通股的出售。该交易以每股94.572美元的价格执行，总销售价值为63,363.24美元。在此次出售之前，克林格于2024年2月28日通过行使衍生证券收购了1,315股股票。这些交易之后，克林格在Moderna的直接持有量为8,557股普通股。
Moderna, Inc. '根据美国证券交易委员会的最新文件，首席法务官香农·泰里姆·克林格于2024年2月29日完成了670股普通股的出售。该交易以每股94.572美元的价格执行，总销售价值为63,363.24美元。在此次出售之前，克林格于2024年2月28日通过行使衍生证券收购了1,315股股票。这些交易之后，克林格在Moderna的直接持有量为8,557股普通股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息